Committed to Hepatology

A commitment to effective HCV and HBV diagnosis and monitoring since 1993

Hepatitis B and C are among the most common viral infections in the world, with more than 240 million people  affected by a chronic hepatitis B infection1 and about 130 to 150 million  people with chronic hepatitis C.2

Every day, approximately 4,000 people die from the consequences of viral hepatitis –1.4 million people every year.3

95% of people living with viral hepatitis don’t know.

This year sees the publication of the first ever World Health Organization’s Global Strategy for Viral Hepatitis, which sets a goal of eliminating viral hepatitis as a major public health threat by 2030.

Roche is committed to the fight against viral hepatitis, with a comprehensive portfolio of medicines and diagnostic tests to diagnose, confirm, manage and treat the disease.

References

  1. World Health Organization. Hepatitis C Fact Sheet Updated July 2016. Last accessed July 2016 at http://www.who.int/mediacentre/factsheets/fs2014/en/
  2. World Health Organization. Hepatitis C Fact Sheet Updated July 2016. Last accessed July 2016 at http://www.who.int/mediacentre/factsheets/fs164/en/
  3. World Health Organization. World Hepatitis Day. Last accessed July 2016 at http://www.who.int/campaigns/hepatitis-day/2016/event/en/